Evolution of surgical modalities in the management of rhinophyma: our experience.

Laser ablation Medical treatment Pathophysiology Rhinophyma Rosacea Surgery

Journal

The British journal of oral & maxillofacial surgery
ISSN: 1532-1940
Titre abrégé: Br J Oral Maxillofac Surg
Pays: Scotland
ID NLM: 8405235

Informations de publication

Date de publication:
02 2021
Historique:
received: 18 06 2020
accepted: 12 08 2020
pubmed: 22 9 2020
medline: 24 4 2021
entrez: 21 9 2020
Statut: ppublish

Résumé

Rhinophyma is a progressive disease of the nose, which is characterised by skin thickening and sebaceous hyperplasia. Patients with rhinophyma are often stigmatised due to worsening disfigurement of their nose. This can also result in functional impairment such as reduced nasal patency. Severe cases of rhinophyma are best managed with varied surgical interventions, as there is no clear 'gold standard' treatment that has been described. We present our experiences in the management of rhinophyma and the evolution of treatment modalities that have been employed over a nine-year period.

Identifiants

pubmed: 32951923
pii: S0266-4356(20)30462-9
doi: 10.1016/j.bjoms.2020.08.071
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

222-227

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Auteurs

M Goh (M)

Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK. Electronic address: meigoh@nhs.net.

Z B Gönen (ZB)

Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK; Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.

A Sayan (A)

Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK.

V Ilankovan (V)

Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH